Stephen V Burks1,2,3, Jon E Anderson4, Matthew Bombyk1, Rebecca Haider1, Derek Ganzhorn1, Xueyang Jiao1, Connor Lewis4, Andrew Lexvold4, Hong Liu1, Jiachen Ning1, Alice Toll4, Jeffrey S Hickman5, Erin Mabry5, Mark Berger6, Atul Malhotra7, Charles A Czeisler8,9, Stefanos N Kales9,10,11. 1. Division of Social Science, University of Minnesota, Morris, MN. 2. Center for Transportation Studies, University of Minnesota, Morris, MN. 3. Institute for the Study of Labor (IZA), Bonn, DE. 4. Division of Science and Math, University of Minnesota, Morris, MN. 5. Virginia Tech Transportation Institute, Blacksburg, VA. 6. Precision Pulmonary Diagnostics, Houston, TX. 7. Division of Pulmonary and Critical Care Medicine, School of Medicine, University of California, San Diego, San Diego, CA. 8. Division of Sleep Medicine and Circadian Disorders, Department of Medicine and Neurology, Brigham and Women's Hospital, Boston, MA. 9. Division of Sleep Medicine, Harvard Medical School, Boston, MA. 10. Department of Environmental and Occupational Medicine and Epidemiology, Harvard TH Chan School of Public Health, Boston, MA. 11. Occupational Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA.
Abstract
STUDY OBJECTIVES: To evaluate the effect of an employer-mandated obstructive sleep apnea (OSA) program on the risk of serious preventable truck crashes. METHODS: Data are from the first large-scale, employer-mandated program to screen, diagnose, and monitor OSA treatment adherence in the US trucking industry. A retrospective analysis of cohorts was constructed: polysomnogram-diagnosed drivers (OSA positive n = 1,613, OSA negative n = 403) were matched to control drivers unlikely to have OSA (n = 2,016) on two factors affecting crash risk, experience-at-hire and length of job tenure; tenure was matched on the date of each diagnosed driver's polysomnogram. Auto-adjusting positive airway pressure (APAP) treatment was provided to all cases (i.e. OSA positive drivers); treatment adherence was objectively monitored. Cases were grouped by treatment adherence: "Full Adherence" (n = 682), "Partial Adherence" (n = 571), or "No Adherence" (n = 360). Preventable Department-of-Transportation-reportable crashes/100,000 miles were compared across study subgroups. Robustness was assessed. RESULTS: After the matching date, "No Adherence" cases had a preventable Department of Transportation-reportable crash rate that was fivefold greater (incidence rate ratio = 4.97, 95% confidence interval: 2.09, 10.63) than that of matched controls (0.070 versus 0.014 per 100,000 miles). The crash rate of "Full Adherence" cases was statistically similar to controls (incidence rate ratio = 1.02, 95% confidence interval: 0.48, 2.04; 0.014 per 100,000 miles). CONCLUSIONS: Nontreatment-adherent OSA-positive drivers had a fivefold greater risk of serious preventable crashes, but were discharged or quit rapidly, being retained only one-third as long as other subjects. Thus, the mandated program removed risky nontreatment-adherent drivers and retained adherent drivers at the study firm. Current regulations allow nonadherent OSA cases to drive at another firm by keeping their diagnosis private. COMMENTARY: A commentary on this article appears in this issue on page 961.
STUDY OBJECTIVES: To evaluate the effect of an employer-mandated obstructive sleep apnea (OSA) program on the risk of serious preventable truck crashes. METHODS: Data are from the first large-scale, employer-mandated program to screen, diagnose, and monitor OSA treatment adherence in the US trucking industry. A retrospective analysis of cohorts was constructed: polysomnogram-diagnosed drivers (OSA positive n = 1,613, OSA negative n = 403) were matched to control drivers unlikely to have OSA (n = 2,016) on two factors affecting crash risk, experience-at-hire and length of job tenure; tenure was matched on the date of each diagnosed driver's polysomnogram. Auto-adjusting positive airway pressure (APAP) treatment was provided to all cases (i.e. OSA positive drivers); treatment adherence was objectively monitored. Cases were grouped by treatment adherence: "Full Adherence" (n = 682), "Partial Adherence" (n = 571), or "No Adherence" (n = 360). Preventable Department-of-Transportation-reportable crashes/100,000 miles were compared across study subgroups. Robustness was assessed. RESULTS: After the matching date, "No Adherence" cases had a preventable Department of Transportation-reportable crash rate that was fivefold greater (incidence rate ratio = 4.97, 95% confidence interval: 2.09, 10.63) than that of matched controls (0.070 versus 0.014 per 100,000 miles). The crash rate of "Full Adherence" cases was statistically similar to controls (incidence rate ratio = 1.02, 95% confidence interval: 0.48, 2.04; 0.014 per 100,000 miles). CONCLUSIONS: Nontreatment-adherent OSA-positive drivers had a fivefold greater risk of serious preventable crashes, but were discharged or quit rapidly, being retained only one-third as long as other subjects. Thus, the mandated program removed risky nontreatment-adherent drivers and retained adherent drivers at the study firm. Current regulations allow nonadherent OSA cases to drive at another firm by keeping their diagnosis private. COMMENTARY: A commentary on this article appears in this issue on page 961.
Authors: Indira Gurubhagavatula; Greg Maislin; Jonathan E Nkwuo; Allan I Pack Journal: Am J Respir Crit Care Med Date: 2004-05-13 Impact factor: 21.405
Authors: C R C Moreno; F A Carvalho; C Lorenzi; L S Matuzaki; S Prezotti; P Bighetti; F M Louzada; G Lorenzi-Filho Journal: Chronobiol Int Date: 2004 Impact factor: 2.877
Authors: Lawrence J Epstein; David Kristo; Patrick J Strollo; Norman Friedman; Atul Malhotra; Susheel P Patil; Kannan Ramar; Robert Rogers; Richard J Schwab; Edward M Weaver; Michael D Weinstein Journal: J Clin Sleep Med Date: 2009-06-15 Impact factor: 4.062
Authors: Mark E Howard; Anup V Desai; Ronald R Grunstein; Craig Hukins; John G Armstrong; David Joffe; Philip Swann; Donald A Campbell; Robert J Pierce Journal: Am J Respir Crit Care Med Date: 2004-08-18 Impact factor: 21.405
Authors: M Melani Lyons; Jan F Kraemer; Radha Dhingra; Brendan T Keenan; Niels Wessel; Martin Glos; Thomas Penzel; Indira Gurubhagavatula Journal: J Clin Sleep Med Date: 2019-01-15 Impact factor: 4.062
Authors: Stephen V Burks; Jon E Anderson; Bibhudutta Panda; Rebecca Haider; Tim Ginader; Nicole Sandback; Darya Pokutnaya; Derek Toso; Natalie Hughes; Humza S Haider; Resa Brockman; Alice Toll; Nicholas Solberg; Jesse Eklund; Michael Cagle; Jeffery S Hickman; Erin Mabry; Mark Berger; Charles A Czeisler; Stefanos N Kales Journal: Sleep Date: 2020-04-15 Impact factor: 5.849
Authors: Matthew S Thiese; Richard J Hanowski; Stefanos N Kales; Richard J Porter; Gary Moffitt; Nan Hu; Kurt T Hegmann Journal: J Occup Environ Med Date: 2017-02 Impact factor: 2.162
Authors: Jason P Sullivan; Conor S O'Brien; Laura K Barger; Shantha M W Rajaratnam; Charles A Czeisler; Steven W Lockley Journal: Sleep Date: 2017-01-01 Impact factor: 5.849